News tagged with latent tb
Team finds molecule that polices TB lung infection, could lead to vaccine
The presence of a certain molecule allows the immune system to effectively police tuberculosis (TB) of the lungs and prevent it from turning into an active and deadly infection, according to a new study led by researchers ...
Diseases, Conditions, Syndromes
Jan 02, 2013 |
not rated yet |
0
|
Technology brings new life to the study of diseases in old bones
A study led by The University of Manchester has demonstrated that new technology that can analyse millions of gene sequences in a matter of seconds is an effective way to quickly and accurately identify diseases in skeletons.
Medical research
Oct 22, 2012 |
not rated yet |
0
|
Scientists explain unique activity of TB drug pyrazinamide
Pyrazinamide has been used in combination with other drugs as a first-line treatment for people with tuberculosis (TB) since the 1950s, but exactly how the drug works has not been well understood.
Medical research
Aug 11, 2011 |
not rated yet |
0
|
Scientists gain new understanding of latent tuberculosis
Scientists at the Forsyth have gained new insight on how Tuberculosis (TB) remains a global epidemic. Although drugs have been available to fight TB for 50 years, the disease still infects nearly 2.2 billion people worldwide ...
Diseases, Conditions, Syndromes
Jan 30, 2013 |
not rated yet |
0
US urges shorter treatment for TB
US health authorities on Thursday urged a 12-week drug regimen for people with latent tuberculosis as an effective alternative to the current nine-month regimen which many people do not finish.
Diseases, Conditions, Syndromes
Dec 08, 2011 |
not rated yet |
0
Immigrant screening misses majority of imported latent TB, finds study
Current UK procedures to screen new immigrants for tuberculosis (TB) fail to detect more than 70 per cent of cases of latent infection, according to a new study published in The Lancet Infectious Diseases.
Diseases, Conditions, Syndromes
Apr 21, 2011 |
not rated yet |
0
Vaccine targeting latent TB enters clinical testing
Statens Serum Institut and Aeras today announce the initiation of the first Phase I clinical trial of a new candidate TB vaccine designed to protect people latently infected with TB from developing active TB disease. The ...
Medications
Dec 01, 2011 |
not rated yet |
0
